Literature DB >> 24267964

Improved long-term outcomes with IMRT: is it better technology or better physics?

Michael J Zelefsky1, Joseph O Deasy.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24267964      PMCID： PMC4786866          DOI： 10.1016/j.ijrobp.2013.09.004

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  8 in total

1.  Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer.

Authors:  Zumre A Alicikus; Yoshiya Yamada; Zhigang Zhang; Xin Pei; Margie Hunt; Marisa Kollmeier; Brett Cox; Michael J Zelefsky
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

2.  Interstitial biodegradable balloon for reduced rectal dose during prostate radiotherapy: results of a virtual planning investigation based on the pre- and post-implant imaging data of an international multicenter study.

Authors:  Corinna Melchert; Eliahu Gez; Günther Bohlen; Giovanni Scarzello; Isaac Koziol; Mitchell Anscher; Shmuel Cytron; Adrian Paz; Taryn Torre; Mathew Bassignani; Fabrizio Dal Moro; Dieter Jocham; Rami Ben Yosef; Benjamin W Corn; György Kovács
Journal:  Radiother Oncol       Date:  2013-02-26       Impact factor: 6.280

3.  Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial.

Authors:  Jeff M Michalski; Yan Yan; Deborah Watkins-Bruner; Walter R Bosch; Kathryn Winter; James M Galvin; Jean-Paul Bahary; Gerard C Morton; Matthew B Parliament; Howard M Sandler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-10-08       Impact factor: 7.038

Review 4.  Radiation dose-volume effects in radiation-induced rectal injury.

Authors:  Jeff M Michalski; Hiram Gay; Andrew Jackson; Susan L Tucker; Joseph O Deasy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

5.  Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer.

Authors:  M J Zelefsky; Z Fuks; L Happersett; H J Lee; C C Ling; C M Burman; M Hunt; T Wolfe; E S Venkatraman; A Jackson; M Skwarchuk; S A Leibel
Journal:  Radiother Oncol       Date:  2000-06       Impact factor: 6.280

6.  Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients.

Authors:  Pedro J Prada; José Fernández; Alvaro A Martinez; Angeles de la Rúa; Jose M Gonzalez; Jose M Fernandez; German Juan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-01       Impact factor: 7.038

7.  Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.

Authors:  Michael J Zelefsky; Marisa Kollmeier; Brett Cox; Anthony Fidaleo; Dahlia Sperling; Xin Pei; Brett Carver; Jonathan Coleman; Michael Lovelock; Margie Hunt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-11       Impact factor: 7.038

8.  Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: a prospective multi-center study.

Authors:  Eliahu Gez; Shmuel Cytron; Rahamin Ben Yosef; Daniel London; Benjamin W Corn; Shlomi Alani; Giovanni Scarzello; Fabrizio Dal Moro; Guido Sotti; Filiberto Zattoni; Ike Koziol; Taryn Torre; Matthew Bassignani; Shalom Kalnicki; Reza Ghavamian; Dukagjin Blakaj; Mitchell Anscher; Martin Sommerauer; Dieter Jocham; Corinna Melchert; Stefan Huttenlocher; Gyoergy Kovacs; Madhur Garg
Journal:  Radiat Oncol       Date:  2013-04-23       Impact factor: 3.481
  8 in total
  1 in total

1.  Determination of topographical radiation dose profiles using gel nanosensors.

Authors:  Karthik Pushpavanam; Sahil Inamdar; Subhadeep Dutta; Tomasz Bista; Thaddeus Sokolowski; Eric Boshoven; Stephen Sapareto; Kaushal Rege
Journal:  Sci Adv       Date:  2019-11-15       Impact factor: 14.136
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.